BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(11): 1239-1249 [PMID: 29568204 DOI: 10.3748/wjg.v24.i11.1239]
URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1239.htm
Number Citing Articles
1
Yumi Tsuchida, Hirofumi Shoda, Tetsuji Sawada, Keishi Fujio. Role of autotaxin in systemic lupus erythematosusFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1166343
2
Ashley Vander Does, Cynthia Levy, Gil Yosipovitch. Cholestatic Itch: Our Current Understanding of Pathophysiology and TreatmentsAmerican Journal of Clinical Dermatology 2022; 23(5): 647 doi: 10.1007/s40257-022-00710-2
3
Alexandros Arjmand, Constantinos T. Angelis, Vasileios Christou, Alexandros T. Tzallas, Markos G. Tsipouras, Evripidis Glavas, Roberta Forlano, Pinelopi Manousou, Nikolaos Giannakeas. Training of Deep Convolutional Neural Networks to Identify Critical Liver Alterations in Histopathology Image SamplesApplied Sciences 2019; 10(1): 42 doi: 10.3390/app10010042
4
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and TreatmentFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
5
Richell Booijink, Fernando Salgado‐Polo, Craig Jamieson, Anastassis Perrakis, Ruchi Bansal. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis EMBO Molecular Medicine 2022; 14(9) doi: 10.15252/emmm.202216333
6
Yasushi Honda, Kento Imajo, Takashi Kobayashi, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Masato Yoneda, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non‐alcoholic fatty liver diseaseHepatology Research 2019; 49(10): 1136 doi: 10.1111/hepr.13382
7
Shereen Abou Bakr Saleh, Khaled Mohamed Abdelwahab, Asmaa Mady Mady, Ghada Abdelrahman Mohamed. The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patientsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00060-w
8
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune ActivationCancers 2019; 11(12): 1867 doi: 10.3390/cancers11121867
9
Takanobu Iwadare, Takefumi Kimura, Taiki Okumura, Shun-ichi Wakabayashi, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, Hideo Kunimoto, Satoshi Shimamoto, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura. Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver diseaseCommunications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00499-7
10
Caiyun Nie, Lei Zhang, Xiaobing Chen, Ying Li, Fushuang Ha, Hua Liu, Tao Han. Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver FailureJournal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00045
11
Ayda Esmaeili, Soha Namazi. Is melatonin effective for pruritus caused by liver disease?Medical Hypotheses 2018; 121: 177 doi: 10.1016/j.mehy.2018.10.004
12
Jacqueline A.G.M. Langedijk, Dagmar Tolenaars, Ruth Bolier, Yi-Té Lee, Amber Meurs, Catherine Williamson, Luciano Adorini, Stan F.J. van de Graaf, Ulrich Beuers, Ronald Oude Elferink. Inhibition of autotaxin by bile salts and bile salt-like molecules increases its expression by feedback regulationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021; 1867(11): 166239 doi: 10.1016/j.bbadis.2021.166239
13
Abhishek Gairola, Aaron Wetten, Jessica Dyson. Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitisExpert Opinion on Investigational Drugs 2024; 33(5): 485 doi: 10.1080/13543784.2024.2343789
14
Leke Wiering, Pallavi Subramanian, Linda Hammerich. Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver DiseaseCellular and Molecular Gastroenterology and Hepatology 2023; 15(6): 1277 doi: 10.1016/j.jcmgh.2023.02.010
15
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima. FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global MetabodemicLife 2021; 11(2): 143 doi: 10.3390/life11020143
16
Charalambos Papadopoulos, Konstantinos Mimidis, Dimitris Papazoglou, George Kolios, Ioannis Tentes, Konstantinos Anagnostopoulos. Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α ReleaseReports of Biochemistry and Molecular Biology 2022; 11(1): 54 doi: 10.52547/rbmb.11.1.54
17
Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P. Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura. 2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver diseaseHepatology Research 2022; 52(4): 352 doi: 10.1111/hepr.13745
18
Hideki Fujii, Norifumi Kawada. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2020; 21(11): 3863 doi: 10.3390/ijms21113863
19
Ali Sepehrinezhad, Ali Shahbazi, Mohammad Taghi Joghataei, Fin Stolze Larsen, Sajad Sahab Negah. Inhibition of autotaxin alleviates pathological features of hepatic encephalopathy at the level of gut–liver–brain axis: an experimental and bioinformatic studyCell Death & Disease 2023; 14(8) doi: 10.1038/s41419-023-06022-5
20
Yoshifumi Morita, Makoto Kurano, Eriko Morita, Satoshi Shimamoto, Koji Igarashi, Motoji Sawabe, Junken Aoki, Yutaka Yatomi. Urinary autotaxin concentrations are associated with kidney injuryClinica Chimica Acta 2020; 509: 156 doi: 10.1016/j.cca.2020.06.019
21
Hatsue Fujino, Mio Tanaka, Michio Imamura, Kei Morio, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Tomokazu Kawaoka, Shoichi Takahashi, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, Hiroshi Aikata, C. Nelson Hayes, Kazuaki Chayama. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitisBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1092-z
22
Jacqueline A. G. M. Langedijk, Ulrich H. Beuers, Ronald P. J. Oude Elferink. Cholestasis-Associated Pruritus and Its PruritogensFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.639674
23
Takanobu Iwadare, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Shun-ichi Wakabayashi, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Sai P. Pydi, Tomoyuki Nakajima, Mai Iwaya, Ayumi Sugiura, Satoru Joshita, Takeshi Uehara, Takeji Umemura. Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patientsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23357-9
24
Ashish Verma, Ishan Kumar, Manish Indal, Sunit Shukla, Pramod Kumar Singh, Ram Chandra Shukla. Variation in hepatic segmental portal venous pulsed wave Doppler flow distribution in patients with NAFLD: A pilot studyUltrasound 2023; 31(4): 300 doi: 10.1177/1742271X231154862
25
Alexandros Arjmand, Constantinos T. Angelis, Alexandros T. Tzallas, Markos G. Tsipouras, Evripidis Glavas, Roberta Forlano, Pinelopi Manousou, Nikolaos Giannakeas. Deep Learning in Liver Biopsies using Convolutional Neural Networks2019 42nd International Conference on Telecommunications and Signal Processing (TSP) 2019; : 496 doi: 10.1109/TSP.2019.8768837
26
Anouk Gijbels, Sophie Schutte, Diederik Esser, Suzan Wopereis, Gerard Bryan Gonzales, Lydia A. Afman. Effects of a 12-week whole-grain or refined wheat intervention on plasma acylcarnitines, bile acids and signaling lipids, and association with liver fat: A post-hoc metabolomics study of a randomized controlled trialFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1026213
27
Nancy Abdel Fattah Ahmed, Ahmed Galal Deiab, Ahmad Shawki Mohammad Hasan, Ahmad Mohamed Yousry Abd Elbaky. Serum autotaxin levels in responders to HCV treatment by direct-acting antiviralsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00051-x
28
Lijuan Zhao, Yan Duan, Zhaoxing Li, Juan Li, Shunxiang Li. Unearthing the Potential Therapeutic Effects of Oxyresveratrol Based on Intrinsic Links between Pharmacological Effects: Implications for the Gut–Liver–Brain AxisPharmaceuticals 2024; 17(8): 1063 doi: 10.3390/ph17081063
29
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, Takahito Katsuyama, Yuichi Iwashita, Jonathan Pham, Satoru Joshita, Sai P. Pydi, Takeji Umemura. Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLDLiver International 2021; 41(3): 505 doi: 10.1111/liv.14776
30
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patientsHepatology Research 2018; 48(13): 1092 doi: 10.1111/hepr.13223
31
Su Jin Kim, Cody Howe, Jonathon Mitchell, Jieun Choo, Alexandra Powers, Angelos Oikonomopoulos, Charalabos Pothoulakis, Daniel W Hommes, Eunok Im, Sang Hoon Rhee. Autotaxin loss accelerates intestinal inflammation by suppressing TLR4‐mediated immune responsesEMBO reports 2020; 21(10) doi: 10.15252/embr.201949332
32
Yuichi Hiyama, Hatsue Fujino, Maiko Namba, Yasutoshi Fujii, Shinsuke Uchikawa, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Shiro Oka. Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogsHepatology Research 2024; 54(11): 981 doi: 10.1111/hepr.14042
33
Ayami Fukiage, Hatsue Fujino, Daiki Miki, Yasutaka Ishii, Masahiro Serikawa, Masataka Tsuge, Michio Imamura, Hiroshi Aikata, C. Nelson Hayes, Kazuaki Chayama. Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune PancreatitisDigestive Diseases and Sciences 2021; 66(4): 1268 doi: 10.1007/s10620-020-06338-8
34
Kazuya Takemura, Etsuko Takizawa, Akihiro Tamori, Mika Nakamae, Hiroshi Kubota, Sawako Uchida-Kobayashi, Masaru Enomoto, Norifumi Kawada, Masayuki Hino. Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis CInternational Journal of Molecular Sciences 2020; 21(12): 4517 doi: 10.3390/ijms21124517
35
Kazuya Takemura, Etsuko Takizawa, Akihiro Tamori, Mika Nakamae, Hiroshi Kubota, Sawako Uchida‐Kobayashi, Masaru Enomoto, Norifumi Kawada, Masayuki Hino. Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis CJournal of Gastroenterology and Hepatology 2021; 36(1): 217 doi: 10.1111/jgh.15114
36
Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura, Takuma Yamamoto, Tatsunori Hosono, Akihiro Yoshida, Ippei Kawanishi, Hideaki Fukushima, Masao Kinoshita, Atsushi Umeda, Yuichi Kinoshita, Kana Fukami, Toshio Miyawaki, Hideki Fujii, Yuichi Yoshida, Miwa Kawanaka, Hideyuki Hyogo, Asahiro Morishita, Hideki Hayashi, Hiroshi Tobita, Kengo Tomita, Tadashi Ikegami, Hirokazu Takahashi, Masato Yoneda, Dae Won Jun, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumJournal of Gastroenterology 2023; 58(2): 79 doi: 10.1007/s00535-022-01932-1
37
Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Tingting Shi, Takashi Himoto, Miwa Tatsuta, Akio Moriya, Tomonori Senoo, Akemi Tsutsui, Takuya Nagano, Koichi Takaguchi, Masafumi Ono, Tsutomu Masaki. Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter studyHepatology International 2023; 17(3): 606 doi: 10.1007/s12072-022-10453-1
38
Shanthi Makka, Shivarla Naveen, Shyam Sai Kamal Puranam, Shekapuram Srikesh. Artificial Intelligence in Biomedical and Modern Healthcare Informatics2025; : 339 doi: 10.1016/B978-0-443-21870-5.00032-7
39
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163